Records containing: Treatment Resistant Depression
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression
-
CLINICAL_TRIALS study record update · 2024-09-19Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus
-
CLINICAL_TRIALS study record update · 2024-08-09An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
-
CLINICAL_TRIALS study record update · 2024-08-07Effectiveness and Safety of Deep Brain Stimulation(DBS) in Treatment-Resistant Depression(TRD)
-
CLINICAL_TRIALS study record update · 2024-08-07Identifying Local Field Potential Biomarkers for Treatment-Resistant Major Depression With Deep Brain Stimulation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-06Computational Psychiatric Approach for Prognosis of Medication-Resistant Depression
-
CLINICAL_TRIALS study record update · 2024-07-10IN Esketamine and IV Ketamine: Multi-site Observational Study Assessing the Effectiveness and Tolerability of Two Novel Therapies for Treatment-resistant Depression.
-
CLINICAL_TRIALS study record update · 2024-06-04A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of Intravenous PCN-101 in Treatment Resistant Depression
-
CLINICAL_TRIALS study record update · 2024-05-21Does Modulation of Glutamate Transmission in the Brain Using a Sub-anaesthetic Dose of Ketamine Affect Autobiographical Memory, Emotional Processing and Decision-making in Treatment-resistant Depression?
-
CLINICAL_TRIALS study record update · 2024-05-08Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2024-05-07rTMS Intervention for DMPFC Treatment of Treatment-Resistant Depression Under the Guidance of Personalized Brain Functional Area Dissection (pBFS) Technology
-
CLINICAL_TRIALS study record update · 2024-05-07Neural and Antidepressant Effects of Propofol
-
CLINICAL_TRIALS study record update · 2024-05-03Safety and Pharmacokinetics of a Novel NMDA Receptor Antagonist Against Brain Related Diseases in Healthy Adult Volunteers: First-in-human, Phase I, Single Dose-escalating, Open Label Study
-
CLINICAL_TRIALS study record update · 2024-04-30Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment Resistant Depression: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-04-30Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
-
CLINICAL_TRIALS study record update · 2024-04-05Higher, Faster, Better: Is an Accelerated Intermittent Theta Burst Stimulation Protocol Compared to Standard 10 Hz Repetitive Transcranial Magnetic Stimulation, More (Cost-) Effective in Patients With Treatment-resistant Depression?
-
CLINICAL_TRIALS study record update · 2024-03-25Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-02-13Personalized Brain Functional Sector-guided rTMS Therapy Over Different Targets for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2024-02-09Stellate Ganglion Block for Major Depressive Disorder: A Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2024-02-09Clinical Predictors of Intravenous Ketamine Response in Treatment-Resistant Depression: A Randomized, Double-Blind, Midazolam-Controlled Pilot Study
-
CLINICAL_TRIALS study record update · 2024-02-07Personalized Brain Functional Sector-guided rTMS Therapy Over Different Targets for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2024-02-06Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression: A Study Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-02-06Personalized Brain Functional Sector-guided rTMS Therapy Over Different Targets for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2024-02-06Personalized Brain Functional Sector-guided rTMS Therapy Over Different Targets for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2024-01-31Salicylic Augmentation in Depression